Maybio Matrix logo — Advancing the future of maxillofacial tissue regeneration wi...

Maybio Matrix

Advancing the future of maxillofacial tissue regeneration with innovative biological scaffold solutions for both medical and aesthetic applications.

Founded 2019 Series A Biopharma, Biotechnology

General Information

Company Name Maybio Matrix
Founded Year 2019
Industries Biopharma, Biotechnology
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Maybio Matrix. To contact Maybio Matrix, visit maybio.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Maybio Matrix compare?

A PDF of Maybio Matrix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Maybio Matrix soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Maybio Matrix

Maybio Matrix is a biopharmaceutical and biotechnology startup founded in 2019. The company is dedicated to advancing the future of maxillofacial tissue regeneration with innovative biological scaffold solutions for both medical and aesthetic applications. The description of the company highlights its focus on research and development, production, and sales of biological scaffold material tailored for maxillofacial tissue regeneration, addressing medical, plastic, and cosmetic clinical needs. Maybio Matrix recently secured a significant milestone by receiving a Series A investment on 14 September 2023. The investment was led by Caixin Industry Fund, Sunz Fund, and Xinhangcheng Holdings, showcasing a strong vote of confidence from prominent investors in the industry. This influx of capital is expected to fuel the company's growth and propel its innovative solutions into the market, potentially shaping the future of maxillofacial tissue regeneration. Overall, Maybio Matrix stands as a promising player in the biopharma and biotechnology industries, with a clear focus on pioneering solutions in the field of maxillofacial tissue regeneration. The recent Series A investment indicates a bright outlook for the company, highlighting its potential to make a significant impact in the medical and aesthetic realms.

Business keywords: Biological Scaffold, Tissue Regeneration, Maxillofacial Surgery, Medical Applications, Aesthetic Applications, Biomedical Research, Regenerative Medicine, Plastic Surgery, Cosmetic Surgery, Bioengineering, Clinical Needs

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 3
Caixin Industry Fund, Sunz Fund +1
14 Sep 2023
Series A Undisclosed 3
Alwin Capital, Redhill Capital +1
16 Aug 2021
Angel Round Undisclosed 1
Redhill Capital
09 Feb 2021

Maybio Matrix Alternatives & Competitors

View All Alternatives
Maybio Matrix vs
inSoma Bio
inSoma Bio United States

Rebuilding you with you.

13 employees
Biopharma, Biotechnology
Maybio Matrix vs
Plcoskin
Plcoskin Korea South

Plcoskin is a MedTech company specializing in reconstructive plastic surgery and regenerative skinca...

Series B
1 employees
Biopharma, Biotechnology
Maybio Matrix vs

Bioteck produce dispositivi medici biologici, avvalendosi di originali processi brevettati

20 employees
Biopharma, Biotechnology

FAQ About Maybio Matrix

Advancing the future of maxillofacial tissue regeneration with innovative biological scaffold solutions for both medical and aesthetic applications.
Maybio Matrix was founded in 2019.
Maybio Matrix operates in Biopharma and Biotechnology. Its work centres on Biological Scaffold, Tissue Regeneration, Maxillofacial Surgery and Medical Applications.
Maybio Matrix has completed 3 funding rounds. The latest funding stage is Series A.
Top alternatives and competitors to Maybio Matrix include inSoma Bio, Plcoskin, BIOTECK S.P.A., Kuros Biosciences, Yuanyin Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Maybio Matrix and inSoma Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Maybio Matrix, https://bouncewatch.com/company/maybio-matrix, updated 28 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes